{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:19:21Z","timestamp":1790785161965,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Young Talents Programme in the Provincial Science and Education of Health Project of the Jiangsu Provincial Health Commission","award":["QNRC2016176"],"award-info":[{"award-number":["QNRC2016176"]}]},{"name":"General Programof the Jiangsu Provincial Health Commission","award":["Z2017014"],"award-info":[{"award-number":["Z2017014"]}]},{"name":"Top Talent Support Program for young and middle-aged people of the Wuxi Health Committee","award":["BJ2020084"],"award-info":[{"award-number":["BJ2020084"]}]},{"name":"General Program of the Wuxi Health Committee","award":["M202013"],"award-info":[{"award-number":["M202013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The mammalian target of rapamycin protein (mTOR) signaling pathway is involved in the pathogenesis of schizophrenia and the mechanism of extrapyramidal adverse reactions to antipsychotic drugs, which might be mediated by an mTOR-dependent autophagy impairment. This study aimed to examine the expression of mTOR pathway genes in patients with schizophrenia treated with olanzapine, which is considered an mTOR inhibitor and autophagy inducer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-two patients with acute schizophrenia who had been treated with olanzapine for four weeks (average dose 14.24\u2009\u00b1\u20094.35\u2009mg\/d) and 32 healthy volunteers were recruited. Before and after olanzapine treatment, the Positive and Negative Syndrome Scale (PANSS) was used to evaluate the symptoms of patients with schizophrenia, and the mRNA expression levels of mTOR pathway-related genes, including MTOR, RICTOR, RAPTOR, and DEPTOR, were detected in fasting venous blood samples from all subjects using real-time quantitative PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The MTOR and RICTOR mRNA expression levels in patients with acute schizophrenia were significantly decreased compared with those of healthy controls and further significantly decreased after four weeks of olanzapine treatment. The DEPTOR mRNA expression levels in patients with acute schizophrenia were not significantly different from those of healthy controls but were significantly increased after treatment. The expression levels of the RAPTOR mRNA were not significantly different among the three groups. The pairwise correlations of MTOR, DEPTOR, RAPTOR, and RICTOR mRNA expression levels in patients with acute schizophrenia and healthy controls were significant. After olanzapine treatment, the correlations between the expression levels of the DEPTOR and MTOR mRNAs and between the DEPTOR and RICTOR mRNAs disappeared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Abnormalities in the mTOR pathway, especially DEPTOR and mTORC2, might play important roles in the autophagy mechanism underlying the pathophysiology of schizophrenia and effects of olanzapine treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-021-03394-w","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T05:03:05Z","timestamp":1628053385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alteration in the mRNA expression profile of the autophagy-related mTOR pathway in schizophrenia patients treated with olanzapine"],"prefix":"10.1186","volume":"21","author":[{"given":"Fengwei","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-1287","authenticated-orcid":false,"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"issue":"4","key":"3394_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334\u201341. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.2502.","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"3394_CR2","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.3390\/ijms19082226","volume":"19","author":"L Ryskalin","year":"2018","unstructured":"Ryskalin L, Limanaqi F, Frati A, Busceti CL, Fornai F. mTOR-related brain dysfunctions in neuropsychiatric disorders. Int J Mol Sci. 2018;19(8):2226. https:\/\/doi.org\/10.3390\/ijms19082226.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3394_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1046\/j.1365-2443.2000.00365.x","volume":"5","author":"T Takahashi","year":"2000","unstructured":"Takahashi T, Hara K, Inoue H, Kawa Y, Tokunaga C, Hidayat S, et al. Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro. Genes Cells. 2000;5(9):765\u201375. https:\/\/doi.org\/10.1046\/j.1365-2443.2000.00365.x.","journal-title":"Genes Cells"},{"issue":"4","key":"3394_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1152\/physrev.00038.2014","volume":"95","author":"J Bockaert","year":"2015","unstructured":"Bockaert J, Marin P. mTOR in brain physiology and pathologies. Physiol Rev. 2015;95(4):1157\u201387. https:\/\/doi.org\/10.1152\/physrev.00038.2014.","journal-title":"Physiol Rev"},{"issue":"2","key":"3394_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","volume":"110","author":"K Hara","year":"2002","unstructured":"Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 2002;110(2):177\u201389. https:\/\/doi.org\/10.1016\/S0092-8674(02)00833-4.","journal-title":"Cell."},{"issue":"27","key":"3394_CR6","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1523\/JNEUROSCI.1796-06.2006","volume":"26","author":"EM Schuman","year":"2006","unstructured":"Schuman EM, Dynes JL, Steward O. Synaptic regulation of translation of dendritic mRNAs. J Neurosci. 2006;26(27):7143\u20136. https:\/\/doi.org\/10.1523\/JNEUROSCI.1796-06.2006.","journal-title":"J Neurosci"},{"issue":"5280","key":"3394_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1126\/science.273.5280.1402","volume":"273","author":"H Kang","year":"1996","unstructured":"Kang H, Schuman EM. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science. 1996;273(5280):1402\u20136. https:\/\/doi.org\/10.1126\/science.273.5280.1402.","journal-title":"Science."},{"issue":"5469","key":"3394_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.288.5469.1254","volume":"288","author":"KM Huber","year":"2000","unstructured":"Huber KM, Kayser MS, Bear MF. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science. 2000;288(5469):1254\u20137. https:\/\/doi.org\/10.1126\/science.288.5469.1254.","journal-title":"Science."},{"issue":"5","key":"3394_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/hipo.20078","volume":"15","author":"JB Cracco","year":"2005","unstructured":"Cracco JB, Serrano P, Moskowitz SI, Bergold PJ, Sacktor TC. Protein synthesis-dependent LTP in isolated dendrites of CA1 pyramidal cells. Hippocampus. 2005;15(5):551\u20136. https:\/\/doi.org\/10.1002\/hipo.20078.","journal-title":"Hippocampus."},{"issue":"10","key":"3394_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/14728222.2016.1188080","volume":"20","author":"F Calabrese","year":"2016","unstructured":"Calabrese F, Riva MA, Molteni R. Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target. Expert Opin Ther Targets. 2016;20(10):1195\u2013207. https:\/\/doi.org\/10.1080\/14728222.2016.1188080.","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"3394_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.biopsych.2020.05.029","volume":"88","author":"D Rial","year":"2020","unstructured":"Rial D, Puighermanal E, Chazalon M, Valjent E, Schiffmann SN, de Kerchove d'Exaerde A. Mammalian target of rapamycin-RhoA signaling impairments in direct striatal projection neurons induce altered behaviors and striatal physiology in mice. Biol Psychiatry. 2020;88(12):945\u201354. https:\/\/doi.org\/10.1016\/j.biopsych.2020.05.029.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"3394_CR12","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.biopsych.2020.10.012","volume":"89","author":"R Lin","year":"2021","unstructured":"Lin R, Learman LN, Na CH, Renuse S, Chen KT, Chen PY, et al. Persistently elevated mTOR complex 1-S6 kinase 1 disrupts DARPP-32-dependent D1 dopamine receptor signaling and behaviors. Biol Psychiatry. 2021;89(11):1058\u201372. https:\/\/doi.org\/10.1016\/j.biopsych.2020.10.012.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"3394_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12020-016-1079-2","volume":"56","author":"C Pivonello","year":"2017","unstructured":"Pivonello C, Rousaki P, Negri M, Sarnataro M, Napolitano M, Marino FZ, et al. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study. Endocrine. 2017;56(3):603\u201320. https:\/\/doi.org\/10.1007\/s12020-016-1079-2.","journal-title":"Endocrine."},{"issue":"12","key":"3394_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrn3120","volume":"12","author":"NJ Brandon","year":"2011","unstructured":"Brandon NJ, Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011;12(12):707\u201322. https:\/\/doi.org\/10.1038\/nrn3120.","journal-title":"Nat Rev Neurosci"},{"key":"3394_CR15","doi-asserted-by":"publisher","first-page":"109646","DOI":"10.1016\/j.pnpbp.2019.109646","volume":"94","author":"JM Rosa","year":"2019","unstructured":"Rosa JM, Pazini FL, Olescowicz G, Camargo A, Moretti M, Gil-Mohapel J, et al. Prophylactic effect of physical exercise on A\u03b21-40-induced depressive-like behavior: role of BDNF, mTOR signaling, cell proliferation and survival in the hippocampus. Prog Neuro-Psychopharmacol Biol Psychiatry. 2019;94:109646. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109646.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"3394_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41398-018-0131-9","volume":"8","author":"M Gordillo-Salas","year":"2018","unstructured":"Gordillo-Salas M, Pilar-Cu\u00e9llar F, Auberson YP, Adell A. Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist. Transl Psychiatry. 2018;8(1):84. https:\/\/doi.org\/10.1038\/s41398-018-0131-9.","journal-title":"Transl Psychiatry"},{"key":"3394_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pharmthera.2019.02.017","volume":"199","author":"TH Pham","year":"2019","unstructured":"Pham TH, Gardier AM. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies. Pharmacol Ther. 2019;199:58\u201390. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.02.017.","journal-title":"Pharmacol Ther"},{"key":"3394_CR18","first-page":"122","volume":"10","author":"GH Lee","year":"2016","unstructured":"Lee GH, D'Arcangelo G. New insights into Reelin-mediated signaling pathways. Front Cell Neurosci. 2016;10:122.","journal-title":"Front Cell Neurosci"},{"issue":"23","key":"3394_CR19","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1523\/JNEUROSCI.0887-15.2015","volume":"35","author":"OI Dadalko","year":"2015","unstructured":"Dadalko OI, Siuta M, Poe A, Erreger K, Matthies HJ, Niswender K, et al. mTORC2\/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission. J Neurosci. 2015;35(23):8843\u201354. https:\/\/doi.org\/10.1523\/JNEUROSCI.0887-15.2015.","journal-title":"J Neurosci"},{"issue":"5","key":"3394_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/tpj.2014.84","volume":"15","author":"S Mas","year":"2015","unstructured":"Mas S, Gass\u00f3 P, Parellada E, Bernardo M, Lafuente A. Network analysis of gene expression in peripheral blood identifies mTOR and NF-\u03baB pathways involved in antipsychotic-induced extrapyramidal symptoms. Pharm J. 2015;15(5):452\u201360. https:\/\/doi.org\/10.1038\/tpj.2014.84.","journal-title":"Pharm J"},{"issue":"3","key":"3394_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/tpj.2015.48","volume":"16","author":"S Mas","year":"2016","unstructured":"Mas S, Gass\u00f3 P, Boloc D, Rodriguez N, M\u00e1rmol F, S\u00e1nchez J, et al. Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms. Pharm J. 2016;16(3):293\u2013300. https:\/\/doi.org\/10.1038\/tpj.2015.48.","journal-title":"Pharm J"},{"issue":"1","key":"3394_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.euroneuro.2014.11.011","volume":"25","author":"S Mas","year":"2015","unstructured":"Mas S, Gass\u00f3 P, Ritter MA, Malagelada C, Bernardo M, Lafuente A. Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway. Eur Neuropsychopharmacol. 2015;25(1):51\u20139. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.011.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3394_CR23","doi-asserted-by":"publisher","first-page":"135669","DOI":"10.1016\/j.neulet.2021.135669","volume":"746","author":"S Gu","year":"2021","unstructured":"Gu S, Cui F, Yin J, Fang C, Liu L. Altered mRNA expression levels of autophagy- and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapine. Neurosci Lett. 2021;746:135669. https:\/\/doi.org\/10.1016\/j.neulet.2021.135669.","journal-title":"Neurosci Lett"},{"issue":"1","key":"3394_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/CBM-160196","volume":"19","author":"HA Al Ahmed","year":"2017","unstructured":"Al Ahmed HA, Nada O. E2F3 transcription factor: A promising biomarker in lung cancer. Cancer Biomark. 2017;19(1):21\u20136. https:\/\/doi.org\/10.3233\/CBM-160196.","journal-title":"Cancer Biomark"},{"key":"3394_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274\u201393.","journal-title":"Cell"},{"key":"3394_CR26","doi-asserted-by":"publisher","unstructured":"Hung CM, Garcia-Haro L, Sparks CA, Guertin DA. mTOR-dependent cell survival mechanisms. Cold Spring Harb Perspect Biol. 2012;4(12):a008771. https:\/\/doi.org\/10.1101\/cshperspect.a008771.","DOI":"10.1101\/cshperspect.a008771"},{"issue":"16","key":"3394_CR27","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1111\/bph.12749","volume":"171","author":"M Moschetta","year":"2014","unstructured":"Moschetta M, Reale A, Marasco C, Vacca A, Carrat\u00f9 MR. Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations. Br J Pharmacol. 2014;171(16):3801\u201313. https:\/\/doi.org\/10.1111\/bph.12749.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"3394_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.orcp.2017.07.001","volume":"12","author":"AJ Cox","year":"2018","unstructured":"Cox AJ, Zhang P, Evans TJ, Scott RJ, Cripps AW, West NP. Gene expression profiles in whole blood and associations with metabolic dysregulation in obesity. Obes Res Clin Pract. 2018;12(2):204\u201313. https:\/\/doi.org\/10.1016\/j.orcp.2017.07.001.","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"3394_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.clnu.2016.11.012","volume":"36","author":"DJ Cuthbertson","year":"2017","unstructured":"Cuthbertson DJ, Babraj J, Leese G, Siervo M. Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity. Clin Nutr. 2017;36(6):1716\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2016.11.012.","journal-title":"Clin Nutr"},{"issue":"3","key":"3394_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12031-016-0872-y","volume":"61","author":"L Wang","year":"2017","unstructured":"Wang L, Zhou K, Fu Z, Yu D, Huang H, Zang X, et al. Brain development and Akt signaling: the crossroads of signaling pathway and neurodevelopmental diseases. J Mol Neurosci. 2017;61(3):379\u201384. https:\/\/doi.org\/10.1007\/s12031-016-0872-y.","journal-title":"J Mol Neurosci"},{"issue":"6886","key":"3394_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/417292a","volume":"417","author":"RS Williams","year":"2002","unstructured":"Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature. 2002;417(6886):292\u20135. https:\/\/doi.org\/10.1038\/417292a.","journal-title":"Nature."},{"key":"3394_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","volume":"341","author":"K Switon","year":"2017","unstructured":"Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J. Molecular neurobiology of mTOR. Neuroscience. 2017;341:112\u201353. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.11.017.","journal-title":"Neuroscience."},{"key":"3394_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fpsyt.2017.00225","volume":"8","author":"MS Mostaid","year":"2017","unstructured":"Mostaid MS, Lee TT, Chana G, Sundram S, Shannon Weickert C, Pantelis C, et al. Peripheral transcription of NRG-ErbB pathway genes are upregulated in treatment-resistant schizophrenia. Front Psychiatry. 2017;8:225. https:\/\/doi.org\/10.3389\/fpsyt.2017.00225.","journal-title":"Front Psychiatry"},{"issue":"4","key":"3394_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.euroneuro.2015.02.002","volume":"25","author":"R Machado-Vieira","year":"2015","unstructured":"Machado-Vieira R, Zanetti MV, Teixeira AL, Uno M, Valiengo LL, Soeiro-de-Souza MG, et al. Decreased AKT1\/mTOR pathway mRNA expression in short-term bipolar disorder. Eur Neuropsychopharmacol. 2015;25(4):468\u201373. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.02.002.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3394_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuropharm.2018.07.010","volume":"140","author":"E Dong","year":"2018","unstructured":"Dong E, Guidotti A, Zhang H, Pandey SC. Prenatal stress leads to chromatin and synaptic remodeling and excessive alcohol intake comorbid with anxiety-like behaviors in adult offspring. Neuropharmacology. 2018;140:76\u201385. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.010.","journal-title":"Neuropharmacology."},{"issue":"1","key":"3394_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13046-016-0484-y","volume":"36","author":"V Catena","year":"2017","unstructured":"Catena V, Fanciulli M. Deptor: not only a mTOR inhibitor. J Exp Clin Cancer Res. 2017;36(1):12. https:\/\/doi.org\/10.1186\/s13046-016-0484-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"3394_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pnpbp.2015.08.008","volume":"65","author":"C Fabbri","year":"2016","unstructured":"Fabbri C, Serretti A. Genetics of long-term treatment outcome in bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;65:17\u201324. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.08.008.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"5","key":"3394_CR38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3892\/ijmm.2014.1895","volume":"34","author":"J Davies","year":"2014","unstructured":"Davies J, Zachariades E, Rogers-Broadway KR, Karteris E. Elucidating the role of DEPTOR in Alzheimer's disease. Int J Mol Med. 2014;34(5):1195\u2013200. https:\/\/doi.org\/10.3892\/ijmm.2014.1895.","journal-title":"Int J Mol Med"},{"issue":"2","key":"3394_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"DH Kim","year":"2002","unstructured":"Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110(2):163\u201375. https:\/\/doi.org\/10.1016\/S0092-8674(02)00808-5.","journal-title":"Cell."},{"issue":"1","key":"3394_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41398-018-0330-4","volume":"8","author":"D Boloc","year":"2018","unstructured":"Boloc D, Gortat A, Cheng-Zhang JQ, Garc\u00eda-Cerro S, Rodr\u00edguez N, Parellada M, et al. Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics. Transl Psychiatry. 2018;8(1):276. https:\/\/doi.org\/10.1038\/s41398-018-0330-4.","journal-title":"Transl Psychiatry"},{"issue":"6","key":"3394_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000393","volume":"8","author":"MA Siuta","year":"2010","unstructured":"Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol. 2010;8(6):e1000393. https:\/\/doi.org\/10.1371\/journal.pbio.1000393.","journal-title":"PLoS Biol"},{"key":"3394_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2016.e00222","volume":"2","author":"S Miyata","year":"2016","unstructured":"Miyata S, Kurachi M, Sakurai N, Yanagawa Y, Ishizaki Y, Mikuni M, et al. Gene expression alterations in the medial prefrontal cortex and blood cells in a mouse model of depression during menopause. Heliyon. 2016;2:e00219.","journal-title":"Heliyon."},{"issue":"7","key":"3394_CR43","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/ajmg.b.32559","volume":"174","author":"Y Eriguchi","year":"2017","unstructured":"Eriguchi Y, Kuwabara H, Inai A, Kawakubo Y, Nishimura F, Kakiuchi C, et al. Identification of candidate genes involved in the etiology of sporadic Tourette syndrome by exome sequencing. Am J Med Genet B Neuropsychiatr Genet. 2017;174(7):712\u201323. https:\/\/doi.org\/10.1002\/ajmg.b.32559.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"11","key":"3394_CR44","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1080\/15548627.2020.1713640","volume":"16","author":"M Bernard","year":"2020","unstructured":"Bernard M, Yang B, Migneault F, Turgeon J, Dieud\u00e9 M, Olivier MA, et al. Autophagy drives fibroblast senescence through MTORC2 regulation. Autophagy. 2020;16(11):2004\u201316. https:\/\/doi.org\/10.1080\/15548627.2020.1713640.","journal-title":"Autophagy."},{"key":"3394_CR45","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.celrep.2019.09.072","volume":"29","author":"H Aspernig","year":"2019","unstructured":"Aspernig H, Heimbucher T, Qi W, Gangurde D, Curic S, Yan Y, et al. Mitochondrial Perturbations Couple mTORC2 to Autophagy in C. elegans. Cell Rep. 2019;29:1399\u2013409.e5.","journal-title":"Cell Rep"},{"issue":"20","key":"3394_CR46","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1080\/15384101.2017.1372548","volume":"16","author":"A Lampada","year":"2017","unstructured":"Lampada A, Hochhauser D, Salomoni P. Autophagy and receptor tyrosine kinase signalling: A mTORC2 matter. Cell Cycle. 2017;16(20):1855\u20136. https:\/\/doi.org\/10.1080\/15384101.2017.1372548.","journal-title":"Cell Cycle"},{"issue":"9","key":"3394_CR47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/cns.13127","volume":"25","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Zhao YF, Liu RS, Xiong YJ, Shen X, Wang Y, et al. Olanzapine induced autophagy through suppression of NF-\u03baB activation in human glioma cells. CNS Neurosci Ther. 2019;25(9):911\u201321. https:\/\/doi.org\/10.1111\/cns.13127.","journal-title":"CNS Neurosci Ther"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-021-03394-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T05:12:32Z","timestamp":1628053952000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03394-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3394"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03394-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-284328\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles expressed in the Declaration of Helsinki and was approved by the Ethics Committee of the Wuxi Mental Health Center. Prior to the study, the procedure was fully explained, and written informed consent was obtained from each subject or the first legal guardian if the patient had limited decision-making capacity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}